![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: INS |
Gene summary for INS |
![]() |
Gene information | Species | Human | Gene symbol | INS | Gene ID | 3630 |
Gene name | insulin | |
Gene Alias | IDDM | |
Cytomap | 11p15.5 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | I3WAC9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3630 | INS | HTA12-15-2 | Human | Pancreas | PDAC | 4.21e-07 | 6.33e-01 | 0.2315 |
3630 | INS | HTA12-16-5 | Human | Pancreas | PDAC | 1.34e-09 | 5.46e-01 | 0.047 |
3630 | INS | HTA12-29-1 | Human | Pancreas | PDAC | 1.10e-17 | 5.45e-01 | 0.3722 |
3630 | INS | HTA12-9-1 | Human | Pancreas | PDAC | 1.54e-02 | 3.32e-01 | 0.1532 |
3630 | INS | HTA12-9-2 | Human | Pancreas | PDAC | 3.02e-06 | -8.82e-01 | 0.0835 |
3630 | INS | 3829-EC | Human | Pancreas | PanIN | 3.51e-44 | 7.24e-01 | 0.009 |
3630 | INS | 4347-EC | Human | Pancreas | PanIN | 4.13e-187 | 1.20e+00 | 0.0572 |
3630 | INS | 4741-EC1 | Human | Pancreas | PanIN | 1.43e-45 | 8.66e-01 | 0.0223 |
3630 | INS | 181429 | Human | Pancreas | PDAC | 1.38e-04 | -1.64e+00 | 0.1416 |
3630 | INS | DS20191261Tumor | Human | Pancreas | PDAC | 1.19e-32 | -1.64e+00 | 0.1367 |
3630 | INS | DS20191261TumorKeller | Human | Pancreas | PDAC | 1.12e-06 | -1.64e+00 | 0.1407 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003133111 | Stomach | CAG with IM | positive regulation of cellular catabolic process | 43/1050 | 427/18723 | 1.50e-04 | 2.97e-03 | 43 |
GO:006026311 | Stomach | CAG with IM | regulation of respiratory burst | 6/1050 | 17/18723 | 2.22e-04 | 4.06e-03 | 6 |
GO:000989611 | Stomach | CAG with IM | positive regulation of catabolic process | 47/1050 | 492/18723 | 2.59e-04 | 4.57e-03 | 47 |
GO:000680911 | Stomach | CAG with IM | nitric oxide biosynthetic process | 13/1050 | 76/18723 | 2.85e-04 | 4.96e-03 | 13 |
GO:004542911 | Stomach | CAG with IM | positive regulation of nitric oxide biosynthetic process | 9/1050 | 40/18723 | 2.99e-04 | 5.12e-03 | 9 |
GO:190440711 | Stomach | CAG with IM | positive regulation of nitric oxide metabolic process | 9/1050 | 41/18723 | 3.65e-04 | 5.89e-03 | 9 |
GO:004603111 | Stomach | CAG with IM | ADP metabolic process | 14/1050 | 90/18723 | 4.66e-04 | 7.11e-03 | 14 |
GO:000609611 | Stomach | CAG with IM | glycolytic process | 13/1050 | 81/18723 | 5.40e-04 | 8.07e-03 | 13 |
GO:006201211 | Stomach | CAG with IM | regulation of small molecule metabolic process | 34/1050 | 334/18723 | 5.85e-04 | 8.52e-03 | 34 |
GO:000675711 | Stomach | CAG with IM | ATP generation from ADP | 13/1050 | 82/18723 | 6.10e-04 | 8.79e-03 | 13 |
GO:004518511 | Stomach | CAG with IM | maintenance of protein location | 14/1050 | 94/18723 | 7.30e-04 | 1.00e-02 | 14 |
GO:00066331 | Stomach | CAG with IM | fatty acid biosynthetic process | 20/1050 | 163/18723 | 8.18e-04 | 1.08e-02 | 20 |
GO:001605211 | Stomach | CAG with IM | carbohydrate catabolic process | 19/1050 | 154/18723 | 1.02e-03 | 1.29e-02 | 19 |
GO:004343411 | Stomach | CAG with IM | response to peptide hormone | 39/1050 | 414/18723 | 1.09e-03 | 1.33e-02 | 39 |
GO:004639411 | Stomach | CAG with IM | carboxylic acid biosynthetic process | 31/1050 | 314/18723 | 1.63e-03 | 1.80e-02 | 31 |
GO:001605311 | Stomach | CAG with IM | organic acid biosynthetic process | 31/1050 | 316/18723 | 1.81e-03 | 1.94e-02 | 31 |
GO:000609011 | Stomach | CAG with IM | pyruvate metabolic process | 14/1050 | 106/18723 | 2.38e-03 | 2.36e-02 | 14 |
GO:000599611 | Stomach | CAG with IM | monosaccharide metabolic process | 26/1050 | 257/18723 | 2.67e-03 | 2.58e-02 | 26 |
GO:00459951 | Stomach | CAG with IM | regulation of embryonic development | 10/1050 | 64/18723 | 2.82e-03 | 2.69e-02 | 10 |
GO:0051897 | Stomach | CAG with IM | positive regulation of protein kinase B signaling | 15/1050 | 120/18723 | 2.92e-03 | 2.76e-02 | 15 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Breast | ADJ |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Breast | Healthy |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Breast | IDC |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Breast | Precancer |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Cervix | ADJ |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Cervix | Healthy |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Cervix | Precancer |
NAMPT | INSR | NAMPT_INSR | VISFATIN | CRC | ADJ |
NAMPT | INSR | NAMPT_INSR | VISFATIN | CRC | CRC |
NAMPT | INSR | NAMPT_INSR | VISFATIN | CRC | FAP |
NAMPT | INSR | NAMPT_INSR | VISFATIN | CRC | Healthy |
NAMPT | INSR | NAMPT_INSR | VISFATIN | CRC | MSI-H |
NAMPT | INSR | NAMPT_INSR | VISFATIN | CRC | MSS |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Endometrium | ADJ |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Endometrium | AEH |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Endometrium | EEC |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Endometrium | Healthy |
NAMPT | INSR | NAMPT_INSR | VISFATIN | Esophagus | ESCC |
NAMPT | INSR | NAMPT_INSR | VISFATIN | GC | ADJ |
NAMPT | INSR | NAMPT_INSR | VISFATIN | GC | GC |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |